The first phase was double-masked, while the second phase was an unmasked, optional continuation of the investigation. “[Molidustat oral suspension] is an innovative, needle-free oral suspension option for cats that can be given at-home—no in-clinic injections needed. This innovation sets a new standard of care for cats suffering from the debilitating effects of this disease. It represents a paradigm shift in the early-treatment of CKD-related anemia and helps CKD cats feel more like their feline selves.”1In a series of studies, molidustat oral suspension was shown to have a reasonable expectation of efficacy in managing anemia in CKD cats. The most commonly reported adverse reactions included vomiting, increases in systolic blood pressure and mild transient increase in serum potassium.1References

Source: Washington Post September 13, 2023 14:56 UTC